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Choi et al. [2015] recently evaluated Korean workers exposed to indium compounds to 
assess health outcomes indicative of interstitial lung disease. They found meaningful 
associations between serum indium concentration and the biomarkers Krebs von den 
Lungen-6 (KL-6) and surfactant protein-D (SP-D), as well as interstitial changes on high-
resolution computed tomography (HRCT). Work sites assessed in their study included 
indium-tin oxide (ITO) target manufacturing facilities, indium reclaim factories, and display 
panel manufacturing plants.
We reported similar relationships between health outcomes and indium exposure in workers 
at an ITO production facility that also reclaimed indium in the United States [Cummings et 
al., 2014]. Absent from our study, but included in the Korean assessment, were data from 
workers downstream to the manufacturing of ITO targets, such as display panel 
manufacturing plants that utilize the ITO targets to apply a thin film of ITO by sputtering. 
The extent of occupational exposure to ITO and other indium-containing compounds in 
these downstream industries in the United States remains largely unknown. Hines et al. 
[2013] found that workers at ITO thin film deposition companies were exposed to indium 
between sputtering runs when ITO targets were resurfaced or during cleaning of chamber 
interiors and shields. In fact, personal indium air concentration reached 5.4 mg/m3 for 
cleaning sputter or evaporation chambers [Hines et al., 2013], which is orders of magnitude 
above the Japanese respirable exposure limit of 0.3 mg/m3 [MHLW, 2010].
There is precedent for indium lung disease occurring in exposed workers from downstream 
industries in China. Xiao et al. [2010] reported pulmonary alveolar proteinosis in a worker 
exposed to indium as a “sandblaster” for a mobile phone manufacturing company. This 
worker used aluminum oxide sand to clean material used for sputtering of ITO targets for 
deposition on liquid crystal display (LCD) screens [Xiao et al., 2010]. His serum indium 
measured 151.8 mg/L, indicating exposure, and thoracoscopic lung biopsy revealed only 
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indium deposition, without other components of the sand. The worker underwent whole lung 
lavage but died 58 months after diagnosis [Xiao et al., 2015].
The risk of indium lung disease in the industries responsible for manufacturing ITO targets 
and reclaiming indium from spent targets is now well-established [Omae et al., 2011; 
Cummings et al., 2012]. However, more information is needed to understand the risk to 
workers in downstream industries. We therefore, applaud the effort by Choi et al. to include 
this under-studied group in their research and request that they present their findings by 
industry. Specifically, results limited to the workers from the two display panel 
manufacturing plants could help elucidate a number of important issues. For example, are 
markers of exposure and health similar in downstream workers to those seen in 
manufacturing and reclaim? Or do these outcomes and therefore, risk of indium lung disease 
vary by industry?
If worker exposure to ITO and other indium-containing compounds in downstream 
industries is similar to that in ITO manufacturing and indium reclaim, there are potentially 
far-reaching implications. At the very least, a more in-depth review of industries that utilize 
ITO targets in their processes would be warranted, to determine the extent of worker 
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